Henning Kelbæk

8PUBLICATIONS
78CO-AUTHORS
Dental therapeutics, pharmacology and toxicologyCardiology (incl. cardiovascular diseases)Predictive and prognostic markersExercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 02, 2026
Final 5-Year Results of Abluminal Groove-Filled Biodegradable-Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent in Patients With Diabetes: Results of the TARGET AC Trial.

|Sep 02, 2026
Complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease: 10-year outcome from the DANAMI-3-PRIMULTI trial.

|May 20, 2025
10-Year Outcomes of Deferred or Conventional Stent Implantation in Patients With STEMI (DANAMI-3-DEFER).

Jasmine Melissa Marquard, Thomas Engstrøm, Henning Kelbæk

|Sep 25, 2024
Impact of Lipidic Plaque on In-Stent and Stent Edge-Related Events After PCI in Myocardial Infarction: A PROSPECT II Substudy.

Lars Kjøller-Hansen, Akiko Maehara, Henning Kelbæk

|Sep 01, 2024
Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis.

Gianluca Campo, Felix Böhm, Thomas Engstrøm

|Aug 25, 2023
Biodegradable-Polymer or Durable-Polymer Stents in Patients at High Bleeding Risk: A Randomized, Open-Label Clinical Trial.

Marco Valgimigli, Adrian Wlodarczak, Ralph Tölg

Pageof 2

Frequent Collaborators

5 joint publications

Thomas Engstrøm

4 joint publications

Frants Pedersen

4 joint publications

Lars Køber

2 joint publications

Stefan James